Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.

Literature DB >> 7332725

Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.

G Sager, V Hansteen, I Aakesson, S Jacobsen.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1981 PMID： 7332725 PMCID： PMC1401961 DOI： 10.1111/j.1365-2125.1981.tb01279.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

25 in total

1. Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors: R P Noble
Journal: J Lipid Res Date: 1968-11 Impact factor: 5.922

2. Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors: G Mancini; A O Carbonara; J F Heremans
Journal: Immunochemistry Date: 1965-09

3. The effect of small doses of heparin on platelet adhesiveness and lipoprotein-lipase activity before and after operation.

Authors: J M Ham; W W Slack
Journal: Br J Surg Date: 1968-03 Impact factor: 6.939

4. Colorimetric determination of free fatty acids.

Authors: R R Lauwerys
Journal: Anal Biochem Date: 1969-11 Impact factor: 3.365

5. Serum lipoprotein pattern in myocardial infarction.

Authors: S C Enger; S Ritland
Journal: Acta Med Scand Date: 1970-05

6. Heparin and ventricular arrhythmias after myocardial infarction.

Authors: J V Russo; S Margolis; G C Friesinger; R S Ross
Journal: Lancet Date: 1970-12-19 Impact factor: 79.321

7. [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors: M Eggstein; F H Kreutz
Journal: Klin Wochenschr Date: 1966-03-01

8. Removal of fatty acids from serum albumin by charcoal treatment.

Authors: R F Chen
Journal: J Biol Chem Date: 1967-01-25 Impact factor: 5.157

9. Photometric "titration" of free fatty acids with the Technicon AutoAnalyzer.

Authors: E Lorch; K F Gey
Journal: Anal Biochem Date: 1966-08 Impact factor: 3.365

10. Lipid composition of human serum lipoproteins.

Authors: V P Skipski; M Barclay; R K Barclay; V A Fetzer; J J Good; F M Archibald
Journal: Biochem J Date: 1967-08 Impact factor: 3.857

10 in total

Review 1. Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors: R Zini; P Riant; J Barré; J P Tillement
Journal: Clin Pharmacokinet Date: 1990-09 Impact factor: 6.447

Review 2. Hepatic drug metabolism and aging.

Authors: C Durnas; C M Loi; B J Cusack
Journal: Clin Pharmacokinet Date: 1990-11 Impact factor: 6.447

3. Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration.

Authors: S Urien; D Morin; A Renouard; I Rocher; J P Tillement
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953

Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.

1. Electrophoretic separation of plasma lipoproteins in agarose gel.

2. Immunochemical quantitation of antigens by single radial immunodiffusion.

3. The effect of small doses of heparin on platelet adhesiveness and lipoprotein-lipase activity before and after operation.

4. Colorimetric determination of free fatty acids.

5. Serum lipoprotein pattern in myocardial infarction.

6. Heparin and ventricular arrhythmias after myocardial infarction.

7. [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

8. Removal of fatty acids from serum albumin by charcoal treatment.

9. Photometric "titration" of free fatty acids with the Technicon AutoAnalyzer.

10. Lipid composition of human serum lipoproteins.

Review 1. Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Review 2. Hepatic drug metabolism and aging.

3. Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration.

Review 4. Plasma protein binding of drugs in the elderly.

5. Influence of age on serum protein binding of propranolol.

6. beta-blocker plasma concentrations and inflammatory disease: clinical implications.

7. Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.

8. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.

9. Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus.

Review 10. Individual variation in first-pass metabolism.